In case of male patients: either patient partners or patients themselves must use an effective method of avoiding pregnancy for at least 4 weeks prior to study drug administration, during study and up to 30 days after the last dose of study drug or till next chemotherapy cycle [clinicaltrials_resource:0f01b4ea8df330ac4e4f6c03d8fabab2]

In case of male patients: either patient partners or patients themselves must use an effective method of avoiding pregnancy for at least 4 weeks prior to study drug administration, during study and up to 30 days after the last dose of study drug or till next chemotherapy cycle [clinicaltrials_resource:0f01b4ea8df330ac4e4f6c03d8fabab2]